Recombinant erythropoietin failed to correct anemia in Fanconi syndrome

Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trial.

Leukemia·2024

Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia.

Journal of internal medicine·2017

Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial.

Leukemia·2017

Long-term outcome of older patients with newly diagnosed de novo acute promyelocytic leukemia treated with ATRA plus anthracycline-based therapy.

Leukemia·2017

Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio.

Leukemia·2016

6-Mercaptopurine, Still Valuable for the Palliative Treatment of Acute Myeloid Leukaemia.

Hematology (Amsterdam, Netherlands)·2016

C3- and C5-deficient murine cells exhibit severe mitochondrial defects, indicating a pivotal, novel role of innate immunity in regulating hematopoiesis at the electron transfer chain level.

Leukemia·2026

Clinical evaluation of AI-assisted quantitative marrow fibrosis assessment using Continuous Indexing of Fibrosis (CIF).

Leukemia·2026

Targeting CD38 with bispecific antibody XmAb 18968 in patients with relapsed/refractory acute myeloid leukemia and T-cell acute lymphoblastic leukemia.

Leukemia·2026

Circulating tumor cells identify a disseminated genomic high-risk phenotype within IMS-IMWG 2025 staging in newly diagnosed multiple myeloma.

Leukemia·2026

Functional characterization of snoRNA-derived RNA (sdRNA) expression in healthy hematopoiesis and acute myeloid leukemia.

Leukemia·2026

Csnk1a1 E98 mutations rewire signaling and metabolism in del(5q) myelodysplastic neoplasms.

Leukemia·2026

Will the Knee Outlive the Patient? Kaplan-Meier Systematically Overstates the Lifetime Risk of Revision After Total Knee Arthroplasty.

JB & JS open access·2026

Primary Breast Involvement in Erdheim-Chester Disease: A Rare Presentation.

Case reports in radiology·2026

Vepdegestrant: First Approval.

Drugs·2026

Fenthion: MAK Value Documentation, addendum - Translation of the German version from 2024.

The MAK collection for occupational health and safety·2026

Propoxur: MAK Value Documentation, addendum - Translation of the German version from 2024.

The MAK collection for occupational health and safety·2026

EPN (O-ethyl-O-(4-nitrophenyl)-phenylthiophosphonate): MAK Value Documentation, addendum - Translation of the German version from 2024.

The MAK collection for occupational health and safety·2026

Related Experiment Videos

Recombinant erythropoietin failed to correct anemia in Fanconi syndrome

Related Concept Videos

Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trial.

Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia.

Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial.

Long-term outcome of older patients with newly diagnosed de novo acute promyelocytic leukemia treated with ATRA plus anthracycline-based therapy.

Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio.

6-Mercaptopurine, Still Valuable for the Palliative Treatment of Acute Myeloid Leukaemia.

C3- and C5-deficient murine cells exhibit severe mitochondrial defects, indicating a pivotal, novel role of innate immunity in regulating hematopoiesis at the electron transfer chain level.

Clinical evaluation of AI-assisted quantitative marrow fibrosis assessment using Continuous Indexing of Fibrosis (CIF).

Targeting CD38 with bispecific antibody XmAb 18968 in patients with relapsed/refractory acute myeloid leukemia and T-cell acute lymphoblastic leukemia.

Circulating tumor cells identify a disseminated genomic high-risk phenotype within IMS-IMWG 2025 staging in newly diagnosed multiple myeloma.

Functional characterization of snoRNA-derived RNA (sdRNA) expression in healthy hematopoiesis and acute myeloid leukemia.

Csnk1a1 E98 mutations rewire signaling and metabolism in del(5q) myelodysplastic neoplasms.

Will the Knee Outlive the Patient? Kaplan-Meier Systematically Overstates the Lifetime Risk of Revision After Total Knee Arthroplasty.

Primary Breast Involvement in Erdheim-Chester Disease: A Rare Presentation.

Vepdegestrant: First Approval.

Fenthion: MAK Value Documentation, addendum - Translation of the German version from 2024.

Propoxur: MAK Value Documentation, addendum - Translation of the German version from 2024.

EPN (O-ethyl-O-(4-nitrophenyl)-phenylthiophosphonate): MAK Value Documentation, addendum - Translation of the German version from 2024.

Related Experiment Videos

Recombinant erythropoietin failed to correct anemia in Fanconi syndrome

Related Concept Videos

Related Articles